Saccomano Nicholas A 4
4 · ARRAY BIOPHARMA INC · Filed Apr 3, 2019
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-04-01−6,875→ 6,875 totalExercise: $0.00→ Common Stock (6,875 underlying) - Tax Payment
Common Stock
2019-04-01$24.60/sh−6,048$148,781→ 150,190 total - Exercise/Conversion
Restricted Stock Units
2019-04-01−6,875→ 0 totalExercise: $0.00→ Common Stock (6,875 underlying) - Exercise/Conversion
Common Stock
2019-04-01+13,750→ 156,238 total
Footnotes (4)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted on April 1, 2015 and April 1, 2016, as a result of the vesting of one fourth of such RSUs.
- [F2]Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- [F3]The RSUs vested and settled in stock in four equal annual installments beginning April 1, 2015.
- [F4]The RSUs vest and will be settled in stock in four equal annual installments beginning April 1, 2016.